Inventor · disambiguated record
Caroline Reiss
Also filed as: REISS CAROLINE · REISS CAROLINE W
6 granted patents·9 pending applications·6 citations·filing 2019–2025
73Inventor score
Top patents by PatentIndex Score
15 records- 0190US11207416B2Compositions and methods for targeted RNA deliveryVERVE THERAPEUTICS INC·Filed 2021·Granted Dec 28, 2021·4 cites·28 claims
- 0289US11801306B2Compositions and methods for targeted RNA deliveryVERVE THERAPEUTICS INC·Filed 2021·Granted Oct 31, 2023·2 cites·25 claims
- 0381US2025152746A1Base editing of angptl3 and methods of using same for treatment of diseaseVERVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0480US2024390523A1Base editing of pcsk9 and methods of using same for treatment of diseaseVERVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0572US2025084409A1Compositions and methods for capping rnasVERVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0671US12264175B2Compositions and methods for capping RNASVERVE THERAPEUTICS INC·Filed 2023·Granted Apr 1, 2025·0 cites·6 claims
- 0771US12029795B2Base editing of PCSK9 and methods of using same for treatment of diseaseVERVE THERAPEUTICS INC·Filed 2021·Granted Jul 9, 2024·0 cites·24 claims
- 0867US2024390520A1Gene editing of pcsk9 or angptl3 and compositions and methods of using same for treatment of diseaseVERVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0965US12203110B2RNA-programmable endonuclease systems and uses thereofCRISPR THERAPEUTICS AG·Filed 2019·Granted Jan 21, 2025·0 cites·10 claims
- 1065US12115230B2Base editing of ANGPTL3 and methods of using same for treatment of diseaseVERVE THERAPAUTICS INC·Filed 2021·Granted Oct 15, 2024·0 cites·22 claims
- 1162US2022364078A1Mrna large scale synthesis and purificationCRISPR THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 1261US2024011023A1Hybridized guide nucleic acids for use with template-based gene editorsVERVE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1359US2025236636A1Compositions and methods for capping rnasVERVE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1458US2025320477A1Novel rna-programmable endonuclease systems and uses thereofCRISPR THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 1555US2023134582A1Chemically modified guide rnas for genome editing with cas12bVERVE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Caroline Reiss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →